The Incredible Shrinking Firms Of Hedge Fund Billionaires
Four months ago, things were going great for Bill Ackman. The billionaire’s Pershing Square hedge fund had ridden its big and controversial trade on drug makers Allergan and Valeant, posting huge gains in the previous calendar year. By the end of July 2015, Ackman’s hedge fund was up by another…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Forbes

